Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development

Cancer Research

Volumn 75, Issue 2, 2015, Pages 306-315

  Wang, Jian ^a,b   Cao, Ziquan ^c   Zhang, Xing Mei ^d   Nakamura, Masaki ^a   Sun, Meili ^a,b   Hartman, Johan ^a,d   Harris, Robert A ^d   Sun, Yuping ^b   Cao, Yihai ^a,c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANDONG UNIVERSITY   (China)

^c LINKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CARCINOGENESIS; CELL SPECIFICITY; COLORECTAL CANCER; CONTROLLED STUDY; EMBRYO; ENDOMETRIUM CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MACROPHAGE FUNCTION; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; FEMALE; FIBROSARCOMA; GENETIC TRANSFECTION; GENETICS; LEWIS CARCINOMA; MACROPHAGE; NEOPLASM; PATHOLOGY; TRANSGENIC ANIMAL; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOGENESIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; FIBROSARCOMA; HUMANS; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASMS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; ZEBRAFISH;

EID: 84921056473     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2819     Document Type: Article

References (30)

1. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011;147:275-92.
2. Rouhi P, Jensen LD, Cao Z, Hosaka K, Lanne T, Wahlberg E, et al. Hypoxia-induced metastasis model in embryonic zebrafish. Nat Protoc 2010;5: 1911-8.
3. Rouhi P, Lee SL, Cao Z, Hedlund EM, Jensen LD, Cao Y. Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle 2010;9:913-7.
4. Edelman RR, Warach S. Magnetic resonance imaging (1). N Engl J Med 1993;328:708-16.
5. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
6. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5: 735-43.
7. Lee SL, Rouhi P, Dahl Jensen L, Zhang D, Ji H, Hauptmann G, et al. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A 2009;106:19485-90.
8. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
9. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8.
10. Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014;513:559-63.
11. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002;248:307-18.
12. Weischenfeldt J, Porse B. Bone Marrow-Derived Macrophages (BMM): isolation and applications. CSH Protoc 2008;2008:pdb prot5080.
13. Hosaka K, Yang Y, Seki T, Nakamura M, Andersson P, Rouhi P, et al. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nat Commun 2013;4:2129.
14. Xue Y, Lim S, Yang Y, Wang Z, Jensen LD, Hedlund EM, et al. PDGFBB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nature Med 2012;18:100-10.
15. Hedlund EM, Yang X, Zhang Y, Yang Y, Shibuya M, Zhong W, et al. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs. Proc Natl Acad Sci U S A 2013;110:654-9.
16. Yang Y, Zhang Y, Cao Z, Ji H, Yang X, Iwamoto H, et al. Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci U S A 2013;110:12018-23.
17. Cao Z, Jensen LD, Rouhi P, Hosaka K, Lanne T, Steffensen JF, et al. Hypoxiainduced retinopathy model in adult zebrafish. Nat Protoc 2010;5:1903-10.
18. Mia S, Warnecke A, Zhang XM, Malmstrom V, Harris RA. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGFbeta yields a dominant immunosuppressive phenotype. Scand J Immunol 2014;79:305-14.
19. Cao Y. VEGF-targeted cancer therapeutics-paradoxical effects in endocrine organs. Nat Rev Endocrinol 2014;10:530-9.
20. Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, et al. Forty-year journey of angiogenesis translational research. Sci Transl Med 2011;3:114rv3.
21. Cao Y, Langer R. Optimizing the delivery of cancer drugs that block angiogenesis. Sci Transl Med 2010;2:15ps3.
22. Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, et al. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol 2013;31:e69-72.
23. Harrison ML, Obermueller E, Maisey NR, Hoare S, Edmonds K, Li NF, et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J Clin Oncol 2007;25:4542-9.
24. Grivennikov SI, Greten FR, KarinM. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
25. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014;41:49-61.
26. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007;67:2649-56.
27. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
28. Arbiser JL, Bips M, Seidler A, Bonner MY, Kovach C. Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases. J Am Acad Dermatol 2012;67:e81-3.
29. Munson JM, Fried L, Rowson SA, Bonner MY, Karumbaiah L, Diaz B, et al. Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci Transl Med 2012;4:127ra36.
30. Stoff B, MacKelfresh J, Fried L, Cohen C, Arbiser JL. A nonsteroidal alternative to impetiginized eczema in the emergency room. J Am Acad Dermatol 2010;63:537-9.